Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 34 entries
View as:

Phase I Study of APX005M in Pediatric Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03389802 Org: User:
Start: 03/01/18 End: 06/30/25 Due: 06/30/26

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00098761 Org: User:
Start: 02/28/05 End: 02/29/08 Due: 02/28/09

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00006247 Org: User:
Start: 08/31/00 End: 03/31/06 Due: 03/31/07

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006246 Org: User:
Start: 11/30/00 End: - Due: -

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Phase: N/A Priority: Normal
NCT ID: NCT04743661 Org: User:
Start: 04/04/22 End: 10/30/30 Due: 10/30/31

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01158300 Org: User:
Start: 11/30/10 End: 01/31/15 Due: 01/31/16

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults with Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05934630 Org: User:
Start: 07/12/23 End: 07/12/28 Due: 07/12/29

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00897858 Org: User:
Start: 08/31/06 End: - Due: -

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03387020 Org: User:
Start: 01/13/18 End: 04/01/20 Due: 04/01/21

Genetic Study of Brain Tumors in Young Children

Phase: N/A Priority: Normal
NCT ID: NCT00010101 Org: User:
Start: 03/31/01 End: 08/31/04 Due: 08/31/05

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00572182 Org: User:
Start: 07/31/08 End: 02/28/11 Due: 02/28/12

HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04482933 Org: User:
Start: 09/01/25 End: 02/15/30 Due: 02/15/31

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00053040 Org: User:
Start: 10/31/05 End: - Due: -

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01233479 Org: User:
Start: 05/31/10 End: 08/24/17 Due: 08/24/18

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00047177 Org: User:
Start: 10/31/02 End: 07/31/07 Due: 07/31/08

Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00503724 Org: User:
Start: 06/30/07 End: 05/31/10 Due: 05/31/11

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01836549 Org: User:
Start: 03/31/13 End: 04/30/16 Due: 04/30/17

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02031965 Org: User:
Start: 12/31/13 End: 05/31/16 Due: 05/31/17

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00015899 Org: User:
Start: 01/31/02 End: 03/31/07 Due: 03/31/08

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00112619 Org: User:
Start: 08/31/05 End: - Due: -

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

Phase: N/A Priority: Normal
NCT ID: NCT00010114 Org: User:
Start: 03/31/01 End: 03/31/03 Due: 03/31/04

Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma

Phase: N/A Priority: Normal
NCT ID: NCT02717455 Org: User:
Start: 06/28/16 End: 03/31/24 Due: 03/31/25

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04978727 Org: User:
Start: 07/01/22 End: 02/28/30 Due: 02/28/31

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03904862 Org: User:
Start: 07/25/19 End: 02/21/30 Due: 02/21/31

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01975116 Org: User:
Start: 08/31/13 End: 04/30/15 Due: 04/30/16